DIANT Pharma Inc.
PrivateLast Round
Crowdfunding
May 8, 2025
Est. Valuation
$16.25M
Total Funding Raised
$3.52M
Company Overview
DIANT Pharma Inc. is a biotechnology company that provides continuous, process-controlled manufacturing platforms and services for nanoparticle production.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Smart Manufacturing, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DIANT Pharma Inc. Comparables
Compare DIANT Pharma Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Inside Therapeutics | 82% | |
| Danaher Corporation | 78% | |
| KNAUER Wissenschaftliche Geräte GmbH | 73% | |
DIANT Pharma Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | May 8, 2025 | ||||
| Seed | Mar 12, 2025 | ||||
| Seed | Mar 27, 2023 | ||||
| Pre Seed | Jan 20, 2023 | ||||
| Grant | Feb 15, 2022 | ||||
Convertible Debt | Oct 28, 2021 |
Key People
Founding team and executive leadership
DIANT Pharma Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Connecticut Innovations | Convertible Debt, Pre Seed, Seed |
| National Science Foundation | Seed, Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 1, 2025
Attending the ISPE Product Show on October 1st, 2025.
- Sep 15, 2025
Partnering with RNAV8 Bio for integrated mRNA manufacturing.
DIANT Pharma Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about DIANT Pharma Inc.'s valuation, stock price, and market status.